Forte Biosciences, Inc.

Historical 13F Holders

Symbol
FBRX
CUSIP
34962G208
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 34962G208 since 12/18/2024, largest first.

Filer % of Class Filed
Janus Henderson Group Ltd. 13G/A 9.3% 8/13/2026
Event 6/30/2026
BlackRock, Inc. 13G 5.9% 7/28/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (15)
Ikarian Capital, LLC 13G/A
4.99% 8/14/2025
Event 6/30/2025
Alger Associates, Inc. 13G/A 4.6% 8/7/2026
Event 7/31/2026
Adage Capital Management, L.P. 13G/A
3.4% 8/12/2026
Event 6/30/2026
Millennium Management LLC 13G/A
3.2% 7/16/2026
Event 6/30/2026
Perceptive Advisors LLC 13G/A
2.5% 2/14/2025
Event 12/31/2024
Oliveira Steven Michael 13G/A
2.4% 1/9/2026
Event 1/8/2026
Boothbay Fund Management, LLC 13G/A
0.8% 8/7/2025
Event 6/30/2025
Biotechnology Value Fund L P 13G/A
0.5% 11/14/2025
Event 9/30/2025
Affinity Asset Advisors, LLC 13G/A
0% 11/13/2026
Event 9/30/2026
Federated Hermes, Inc. 13G/A
0% 9/8/2026
Event 8/31/2026
Glazer Capital, LLC 13G/A
0% 11/16/2026
Event 9/30/2026
MPM BioImpact LLC 13G/A 0% 11/13/2026
Event 9/30/2026
Orbimed Advisors LLC 13G/A
0% 11/16/2026
Event 9/30/2026
Point72 Asset Management, L.P. 13G/A
0% 5/15/2026
Event 3/31/2026
Tybourne Capital Management (HK) Ltd 13G/A
0% 11/4/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1 3.00 $231
2026 Q2 86 20.4 M $433M
2026 Q1 69 13.5 M $350M
2025 Q4 59 11.5 M $315M
2025 Q3 42 10.3 M $155M
2025 Q2 35 9.81 M $127M
2025 Q1 30 5.03 M $39.3M
2024 Q4 27 4.28 M $97.1M
2024 Q3 25 737 k $4.12M